ESMO Gyn 2026 – New Frontiers in Gynecologic Oncology: BI Replay

On Demand

Duration: 28 Minutes

Original Date: June 23, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence Senior analyst Max Nisen and disease specialists Tonia Kefala Stavridi and Jilly Woodward as they recap the ESMO Gynecology conference in Vienna on June 17-19. The team will analyze read-outs in Ovarian, Endometrial, and Cervical cancers Highlights include data updates for GSK’s high priority ADC mo-rez in endometrial and ovarian cancer and Eli Lilly and Zymeworks entries in the highly competitive FRa ADC race.

ESMO Gyn 2026 – New Frontiers in Gynecologic Oncology: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.